Poolbeg Pharma #POLB – Interview

Co-founder & #COO of One Three Biotech, Brad Pryde catches up with brr mediauk on the #AI Deal with #POLB Poolbeg Pharma to identify new #drugs & treatments for #RSV.     https://www.youtube.com/watch?v=TnKrI6xCt4s&ab_channel=PoolbegPharma

Poolbeg Pharma #POLB – Article – Further Assets

Artificial Intelligence gives unique insight to #drug discovery by spotting links that humans miss. These links identify new #drugs likely to succeed in clinic. In a crowded industry, #AI gives #POLB the edge Learn more: https://poolbegpharma.com/pipeline/further-assets/…

Poolbeg Pharma #POLB – Upcoming London Webinar

  CEO of Poolbeg Pharma, will be presenting at next weeks London South East webinar. They look forward to providing updates on recent Company news. Register to attend: https://us02web.zoom.us/webinar/register/1716431929653/WN_ZJVzMqdWTgWYBetrouIuFg  

Poolbeg Pharma #POLB – sign licence agreement with AnaBio Technologies to develop oral vaccine platform

  CEO Of Poolbeg Pharma caught up with @Proactive_UK to discuss their oral vaccine discovery platform & rapidly expanding pipeline #POLB 001 POLB 002 POLB 003 Oral Vaccine Discovery Platform AI Powered Drug Programme Vaccine Discovery Platform PredictViral

Vox Market Podcast – Alan Green discusses Revolution Bars #RGB, Blencowe Resources #BRES & Poolbeg Pharma #POLB

Alan Green CEO of Brand Communications talks about: Revolution Bars #RBG Blencowe Resources #BRES Poolbeg Pharma #POLB https://www.voxmarkets.co.uk/articles/alan-green-discusses-revolution-bars-blencowe-resources-poolbeg-pharma-ed98e6d/

Poolbeg Pharma #POLB – Licenses RNA-based immunotherapy asset

Broadcast Event Detail

Poolbeg Pharma #POLB – Growing a Capital Light Company. CEO Jeremy Skillington talks to Alan Green

Poolbeg Pharma #POLB – CEO Jeremy Skillington talks to Alan Green, and explains the ‘capital light’ model used by the company to grow the business. Jeremy talks about the three licensing deals signed by the company over the past few months, including the option agreement to licence MelioVac, the tie up with AnaBio Technologies and today’s […]

Pharma Times – Poolbeg Pharma dives into nasally administered antivirals

Poolbeg Pharma plc #POLB featured in The Pharma Times following this morning’s announcement on our exclusive licence signed with University of Warwick for broad spectrum #rna -based immunotherapy for respiratory virus infections… Full article here    

Alan Green covers AEX Gold #AEXG and Poolbeg Pharma #POLB on this week’s Stockbox Research Talks

Alan Green covers AEX Gold #AEXG and Poolbeg Pharma #POLB on this week’s Stockbox Research Talks

Poolbeg Pharma #POLB CEO Jeremy Skillington talks to BRR Media

Poolbeg Pharma #POLB CEO Jeremy Skillington talks to BRR Media and outlines the progress made in the 5 months post IPO, along with group plans for 2022.